Accenture and Organon Team Up to Drive Digital Transformation for Better Patient and Employee Experiences
November 17 2021 - 1:59PM
Business Wire
Accenture to help build Organon’s next
generation enterprise capabilities with SAP S4/HANA® on AWS
Accenture (NYSE: ACN) has been selected by Organon (NYSE: OGN),
a global health care company, to help establish and manage the
transformation of the company’s enterprise resource planning (ERP)
technology into a cloud-based digital core that will improve
patient and employee experiences.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211117006234/en/
Making Organon’s operating model fit for
the future (Photo: Business Wire)
With a standardized technology platform that integrates business
processes and people, Organon will have real-time analytics at its
fingertips, allowing it to respond more rapidly to the needs of its
patients, customers, and employees.
Organon will use SAP S/4HANA® to help simplify systems and
processes while minimizing disruption. Accenture will deploy the
solution using AWS cloud hosting for scalability and a faster
implementation time, leveraging the jointly developed accelerators
with AWS via the Accenture AWS Business Group. Additionally,
Organon will use Accenture myConcerto® to identify business
challenges, define a transformation vision and build a value case
that guides its roadmap development, delivery, change management
and underpins continuous innovation.
“We are excited to be modernizing technology, simplifying
processes and supporting the flexible adoption of partners, and
providing connected real-time data,” said Davey Sehwani, VP IT
account management at Organon. “By leveraging Accenture’s
comprehensive delivery approach combined with their functional
knowledge across finance, commercial, supply chain and
manufacturing we are putting in place a business operating model
fit for the future.”
“Organon is establishing a foundation that will be essential to
its ability to continue to grow as a company and fulfill its
promise to the various communities it serves, including patients
and its employees,” said Natalia Roberts, Accenture’s client
account lead for Organon. “Blending technology with human
ingenuity, we look forward to helping Organon embrace the power of
change to create holistic value to drive growth."
Steen Moller, Accenture’s Global SAP Life Sciences industry
lead, added: “Organon is investing in a modern and digital ERP core
which will enable the next generation enterprise capabilities
including analytics, automation and cloud. We are honored to
support Organon in this journey to fuel their growth and
innovation."
Accenture’s Life Sciences industry group helps pharmaceutical,
biotech, medical technology, distributor and consumer health
companies combine the latest technology with scientific
breakthroughs to revolutionize how medical treatments are
discovered, developed and delivered to patients around the world.
To learn more, visit
https://www.accenture.com/us-en/industries/life-sciences-index.
For more information, visit http://www.organon.com and connect
on LinkedIn and Instagram.
About Accenture
Accenture is a global professional services company with leading
capabilities in digital, cloud and security. Combining unmatched
experience and specialized skills across more than 40 industries,
we offer Strategy and Consulting, Interactive, Technology and
Operations services — all powered by the world’s largest network of
Advanced Technology and Intelligent Operations centers. Our 624,000
people deliver on the promise of technology and human ingenuity
every day, serving clients in more than 120 countries. We embrace
the power of change to create value and shared success for our
clients, people, shareholders, partners and communities. Visit us
at www.accenture.com.
Any statements in this release that are not historical facts are
forward-looking statements as defined in the U.S. Private
Securities Litigation Reform Act of 1995. All forward-looking
statements are subject to various risks and uncertainties described
in SAP’s filings with the U.S. Securities and Exchange Commission
(“SEC), including its most recent annual report on Form 20-F, that
could cause actual results to differ materially from expectations.
SAP cautions readers not to place undue reliance on these
forward-looking statements which SAP has no obligation to update
and which speak only as of their dates.
SAP and other SAP products and services mentioned herein as well
as their respective logos are trademarks or registered trademarks
of SAP SE in Germany and other countries. Please see
https://www.sap.com/copyright for additional trademark information
and notices. All other product and service names mentioned are the
trademarks of their respective companies.
Copyright ©2021 Accenture. All rights reserved. Accenture and
its logo are registered trademarks of Accenture.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211117006234/en/
Marchell Gillis Accenture +1 678 657 7515 (office) +1 404 409
9430 (mobile) marchell.gillis@accenture.com
Accenture (NYSE:ACN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accenture (NYSE:ACN)
Historical Stock Chart
From Apr 2023 to Apr 2024